Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,599,288
-$240,396 QoQ
Shares Held
29,529
-0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#381
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INGALLS & SNYDER LLC holds $149,411,802 across 12 Drug Manufacturers - General names. AZN ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
135,858 | $34,187,307 | |
| 2 | MRK |
Merck & Co., Inc.
|
203,973 | $26,210,530 | |
| 3 | NVS |
Novartis AG
|
134,587 | $21,092,474 | |
| 4 | JNJ |
Johnson & Johnson
|
74,509 | $18,923,050 | |
| 5 | PFE |
Pfizer Inc
|
730,345 | $17,586,707 | |
| 6 | LLY |
ELI LILLY & Co
|
11,055 | $13,259,699 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
29,529 | $5,599,288 | |
| 8 | AMGN |
Amgen Inc
|
14,885 | $5,390,156 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,599,288 | 29,529 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $5,839,684 | 29,610 | Shares | Other | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||